Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
361-06-001 ISMRM Abstract

Myelin Loss in Olfactory–Limbic Circuits Predicts Olfactory and Memory Impairment in MCI

Primary: Neuro - Alzheimer's Disease
Secondary: Acquisition & Reconstruction - Quantitative Imaging: head and neck
361-06-001 · Quantitative Imaging: Head and Neck II · Monday, 11 May, 5:05 PM–6:00 PM · Digital Posters Row B
Keywords: Alzheimer's Disease Myelin Olfactory dysfunction Amyloid PET Synthetic MRI (SyMRI)
Accepted
Anupa Ekanayake1, Qing Yang2, Senal D Peiris2, Rommy Elyan2, Paul Eslinger2, Sangam Kanekar 3, Ran Pang, Deepak Kalra4, William Jens4, Prasanna Karunanayaka 2
1Radiology, Penn State university, Hershey, United States of America
2Penn State university, Hershey, United States of America
3Radiology, The Pennsylvania State University, Hershey, Pennsylvania, United States of America
4Neurology, The Pennsylvania State University, Hershey, Pennsylvania, United States of America
Presenting Author: Prasanna Karunanayaka

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. [1] Vogel JW, Iturria-Medina Y, Strandberg OT, Smith R, Levitis E, Evans AC, et al. Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease. Nat Commun 2020; 11:2612. doi:10.1038/s41467-020-15701-2; PMID: 32457389. [doi] [pmid]
2. [2] Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease | Nature Communications n.d. https://www.nature.com/articles/s41467-019-14159-1
3. [3] Pajevic S, Basser PJ, Fields RD. Role of myelin plasticity in oscillations and synchrony of neuronal activity. Neuroscience 2014; 276:135–47. doi: 10.1016/j.neuroscience.2013.11.007; PMID: 24291730. [doi] [pmid]
4. [4] Suminaite D, Lyons DA, Livesey MR. Myelinated axon physiology and regulation of neural circuit function. Glia 2019; 67:2050–62. doi:10.1002/glia.23665; PMID: 31233642. [doi] [pmid]
5. [5] Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 1995;16:271–8; discussion 278-284. doi:10.1016/0197-4580(95)00021-6; PMID: 7566337. [doi] [pmid]
6. [6] Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82:239–59. doi:10.1007/BF00308809; PMID: 1759558. [doi] [pmid]
7. [7] Son G, Jahanshahi A, Yoo S-J, Boonstra JT, Hopkins DA, Steinbusch HWM, et al. Olfactory neuropathology in Alzheimer’s disease: a sign of ongoing neurodegeneration. BMB Rep 2021; 54:295–304. doi:10.5483/BMBRep.2021.54.6.055; PMID: 34162463. [doi] [pmid]
8. [8] Fujita S, Gagoski B, Hwang K-P, Hagiwara A, Warntjes M, Fukunaga I, et al. Cross-vendor multiparametric mapping of the human brain using 3D-QALAS: A multicenter and multivendor study. Magn Reson Med 2024; 91:1863–75. doi:10.1002/mrm.29939; PMID: 38192263. [doi] [pmid]
9. [9] Hagiwara A, Warntjes M, Hori M, Andica C, Nakazawa M, Kumamaru KK, et al. SyMRI of the Brain. Invest Radiol 2017; 52:647–57. doi:10.1097/RLI.0000000000000365; PMID: 28257339. [doi] [pmid]
10. [10] Kamagata K, Andica C, Hatano T, Ogawa T, Takeshige-Amano H, Ogaki K, et al. Advanced diffusion magnetic resonance imaging in patients with Alzheimer’s and Parkinson’s diseases. Neural Regen Res 2020; 15:1590. doi:10.4103/1673-5374.276326. [doi]
11. [11] Aung WY, Mar S, Benzinger TL. Diffusion tensor MRI as a biomarker in axonal and myelin damage. Imaging Med 2013; 5:427–40. doi:10.2217/iim.13.49; PMID: 24795779. [doi] [pmid]
12. [12] Depp C, Sun T, Sasmita AO, Spieth L, Berghoff SA, Nazarenko T, et al. Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease. Nature 2023; 618:349–57. doi:10.1038/s41586-023-06120-6; PMID: 37258678. [doi] [pmid]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/361-06-001